Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: Effects on virus-mediated demyelination

European Journal of Pharmacology

Volumn 372, Issue 1, 1999, Pages 75-83

  Lledó, Alberto ^a   Borrell, José ^a   Guaza, Carmen ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Dexamethasone; Hippocampus; Interleukin 1 receptor; Theiler's murine encephalomyelitis virus

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 1 RECEPTOR; IODINE 125; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; FEMALE; HIPPOCAMPUS; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; REGULATORY MECHANISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEMYELINATING DISEASES; DEXAMETHASONE; FEMALE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; POLIOMYELITIS; RECEPTORS, INTERLEUKIN-1; SPECIES SPECIFICITY; THEILOVIRUS; TIME FACTORS;

EID: 0032922060     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00187-9     Document Type: Article

References (59)

1. Akahoshi T., Oppenheim J.J., Mattsushima K. Induction of high affinity interleukin-1 receptors on human peripheral blood lymphocytes by glucocorticoid hormones. J. Exp. Med. 167:1988;924-936.
2. Badovinac V., Mostarica-Stojkovic M., Dinarello C.A., Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 85:1998;87-95.
3. Ban E., Milon G., Prudhomme N., Haour F. Receptors for interleukin-(α and β) in mouse brain: mapping and neuronal localisation in hippocampus. Neuroscience. 43:1991;21-30.
4. Ban E.G., Haour F., Lenstra R. Brain interleukin-1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine. 4:1992;48-54.
5. Barnes P.J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14:1993;436-441.
6. Benveniste E.N. Inflammatory cytokines in the central nervous system: sources, function and mechanisms of action. Am. J. Physiol. 263:1992;C1-C16.
7. Berkenbosch F., van Oers J., del Rey A. Corticotrophin-releasing-factor producing neurones in the rat are activated by interleukin-1. Science. 238:1987;524-526.
8. Betancur C., Lledó A., Borrell J., Guaza C. Corticosteroid regulation of IL-1 receptor in the mouse hippocampus: effects of glucocorticoid treatment, stress, and adrenalectomy. Neuroendocrinology. 59:1994;120-128.
9. Betancur C., Borrell J., Guaza C. Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and lipopolysaccharide. Neuroendocrinology. 62:1995;47-54.
10. Cambronero J.C., Borrell J., Guaza C. Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor induced by interleukin-1. J. Neurosci. Res. 24:1989;470-476.
11. Cambronero J.C., Rivas F.J., Borrell J., Guaza C. Interleukin-1 induces pituitary adrenocorticotropin secretion: evidence for glucocorticoid modulation. Neuroendocrinology. 55:1992;648-654.
12. Chai Z., Alheim K., Lundkvist J., Gatti S., Bartfai T. Subchronic glucocorticoid pretreatment reversibly attenuates IL-1β induced fever in rats; IL-6 mRNA is elevated while IL-1α and IL-1β mRNAs are suppressed, in the CNS. Cytokine. 8:1996;227-237.
13. Clatch R.J., Lipton H.L., Miller S.D. Characterisation of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136:1986;920-927.
14. Clatch R.J., Lipton H.L., Miller S.D. Class II-restricted T-cells responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Microb. Pathol. 3:1987;327-337.
15. Cunningham E.T. Jr., Wada E., Carter D.B., Tracey D.E., Battey J.B., de Souza E.B. In situ histochemical localisation of type I interleukin-1 receptor RNA in the central nervous system, pituitary and adrenal gland of the mouse. J. Neurosci. 12:1992;1101-1114.
16. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood. 97:1996;2095-2147.
17. Fabry Z., Waldschmidt M.M., Hendrickson D., Keiner J., Love-Homan L., Takei L., Hart M.N. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM and Lgp55. J. Neuroimmunol. 36:1992;1-11.
18. Gottschall P.E., Koves K., Mizuno K., Tatsuno I., Arimura A. Glucocorticoid up-regulation of interleukin-1 receptor expression in a glioblastoma cell line. Am. J. Physiol. 261:1991;E362-E368.
19. Goujon E., Parnet P., Cremona S., Goodall G., Dantzer R. Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1β in mice. Am. J. Physiol. 269:1995;R154-R159.
20. Goujon E., Parnet P., Layé S., Combe C., Dantzer R. Adrenalectomy enhances pro-inflammatory cytokines gene expression in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Mol. Brain Res. 36:1996;53-62.
21. Haour F.G., Ban E.M., Milon G.M. Brain interleukin-1 receptors: characterisation and modulation after lipopolysaccharide injection. Prog. Neurol. Endocr. Immunol. 3:1990;196-204.
22. Harbuz M.S., Stephanou A., Sarlis N., Lightman S.L. The effects of recombinant IL-1α, IL-1β or IL-6 on hypothalamus-pituitary-adrenal axis activation. J. Endocrinol. 133:1992;349-355.
23. Hubber S.A., Polgar J., Schultheiss P., Schwimmbeck P. Augmentation of pathogenesis of Coxsackie virus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J. Virol. 68:1994;195-206.
24. Jacobs C.A., Baker P.E., Rous E.R., Picka K.S., Toivola B., Waugh S., Kennedy M.K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146:1991;2983-2989.
25. Kobayashi H., Fukata J., Tominaga T. Regulation of interleukin-1 receptors on AtT-20 mouse pituitary tumor cells. FEBS Lett. 298:1992;100-104.
26. Kohanawa M., Nakane A., Minagawa T. Endogenous gamma interferon produced in central nervous system by systemic infection with Theiler's virus in mice. J. Neuroimmunol. 48:1993;205-212.
27. Knudsen P.J., Dinarello C.A., Strom T.B. Glucocorticoids inhibit the transcription of the interleukin-1 β in U 937 cells. J. Immunol. 139:1987;4129-4134.
28. Layé S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 27:1994;157-162.
29. Lee S.W., Tsou A.P., Chan H., Thomas J., Petrick K., Eugui E.M., Allison A.C. Glucocorticoids selectively inhibit the transcription of the interleukin-1β gene and decrease the stability of interleukin-1β mRNA. Proc. Natl. Acad. Sci. USA. 85:1988;1204-1208.
30. Levy M., Aubert C., Brahic M. Theiler's virus replication in brain macrophages cultured in vitro. J. Virol. 66:1992;3188-3193.
31. Lindsley M.D., Rodriguez M. Characterisation of the inflammatory response in the central nervous system of mice susceptible and resistant to demyelination by Theiler's virus. J. Immunol. 142:1989;2677-2682.
32. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immunol. 11:1975;1147-1155.
33. Lipton H.L., Dal Canto M.C. Theiler's virus-induced demyelination: prevention by immunosuppression. Science. 192:1976;62-64.
34. MacPhee I.A.M., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:1989;431-441.
35. Marquette C., Ceccaldi P.E., Ban E., Weber P., Tsiang H., Haour F. Alteration of interleukin-1α production and interleukin-1α binding sites in mouse brain during rabies infection. Arch. Virol. 141:1996;573-585.
36. Marquette C., Van Dam A.M., Ceccaldi P.E., Weber P., Haour F., Tsiang H. Induction of immunoreactive interleukin-1β and tumor necrosis factor-α in the brains of rabies virus-infected rats. J. Neuroimmunol. 68:1996;45-51.
37. Matsushima K., Taguchi M., Kovacs E.J. Intracellular localisation of human monocytes associated interleukin-1 activity and release of biologically active IL-1 from monocytes by trypsin and plasmin. J. Immunol. 136:1986;2883-2891.
38. Mizel S.B., Killian P.L., Lewis K.A., Chizzonite R.A. The interleukin-1 receptor: interleukin-1 binding and internalisation in T-fibroblasts. J. Immunol. 138:1987;2906-2911.
39. Monteney P., Bureau J.F., Brahic M. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:1997;163-176.
40. Munson P.J., Rodbard D. A versatile computerised approach for characterisation of ligand-binding systems. Ann. Biochem. 107:1980;220-239.
41. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in mouse brain. Mol. Brain Res. 27:1994;63-70.
42. Pena Rossi C., Cash E., Aubert C., Countinho A. Role of macrophages during Theiler's virus infection. J. Virol. 71:1997;3336-3340.
43. Pullen L.C., Park S.H., Miller S.D., Dal Canto M.C., Kim B.S. Treatment with bacterial LPS renders genetically resistant C57 BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:1995;4497-4503.
44. Rothwell N.J. Functions and mechanisms of interleukin-1 in the brain. Trends Pharmacol. Sci. 12:1991;430-436.
45. Rubio N., Capa L. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and resistant strain of mice. Cell Immunol. 149:1993;237-247.
46. Rubio N., Torres C. IL-1, IL-2 and IFN-gamma production by Theiler's virus-induced encephalomyelitis SJL/J mice. Immunology. 74:1991;284-289.
47. Sapatino B.V., Petrescu A.D., Rosenbaum B.A., Smith R. III, Piedrahita J.A., Welsh C.J. Characteristics of cloned cerebrovascular endothelial cells following infection with Theiler's virus: II. Persistent infection. J. Neuroimmunol. 62:1995;127-135.
48. Sato S., Reiner S.L., Jensen M.A., Roos R.P. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 76:1997;213-223.
49. Sims J.E., Giri J.G., Dower S.K. The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72:1994;9-14.
50. Takao T., Culp S.G., de Souza E.B. Reciprocal modulation of interleukin-1 beta and IL-1 receptors by lipopolysaccharide treatment in the mouse. Endocrinology. 13:1993;1497-1504.
51. Tsunoda I., Fujinami R.S. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:1996;673-686.
52. Tsunoda I., Kurtz C.I., Fujinami R.S. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology. 228:1997;388-393.
53. Wada Y., Fujinami R.S. Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am. J. Pathol. 143:1993;221-229.
54. Waksman B.H., Reingold S.C. Viral etiology of multiple sclerosis: where does the truth lie? Trends Neurosci. 9:1986;388-391.
55. Weidenfeld J., Abhramsky O., Ovadia H. Effect of interleukin-1 on ACTH and corticosterone secretion in dexamethasone and adrenalectomised pretreated male rats. Neuroendocrinology. 50:1989;650-654.
56. Wesselingh S.L., Griffin D.E. Local cytokine responses during acute and chronic viral infections of the central nervous system. Semin. Virol. 5:1994;457-463.
57. Wick G., Hu Y., Schwartz S., Kroemer G. Immunoendocrine communication with the hypothalamus-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14:1993;539-563.
58. Wiegers G.J., Reul J.M.H.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. TIPS. 19:1998;317-321.
59. Whitaker J.N., Layton B.A., Herman P.K., Kachelhofer R.D., Burgard S., Bartolucci A.A. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Ann. Neurol. 33:1993;10-17.